.Merck beats profits assumptions, raises sales expectation on strong requirement for top medicines like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Forecasts as Keytruda Sales Rise BloombergMerck Sell: Pharma Titan Posts Sturdy Outcomes, But Expectation Tumbles Short Capitalist's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats revenue as well as sales expectations surrounded by Keytruda advantage, but delivers blended full-year overview MarketWatch.